Accumulating evidence indicates that early-onset T2DM is associated with a more severe disease phenotype, characterized by faster decline in β-cell secretory function, leading to necessitation of insulin therapy earlier in the course of disease, alongside with increased lifetime risk of developing unfavorable long-term outcomes [2]. Here, INS is linked to type 2 diabetes mellitus.